Dysregulation of METTL3 was identified to be a key role in the progression of multiple malignant tumors, such as endometrial cancer (24), bladder cancer (25), pancreatic cancer (26), etc. A number of articles infer that METTL3 can promote tumor progression through multiple mechanisms. Here, METTL3 is linked to pancreatic neoplasm.